Advertisement
UK markets close in 2 hours 25 minutes

  • FTSE 100

    8,119.30
    +40.44 (+0.50%)
     

  • FTSE 250

    19,793.46
    +191.48 (+0.98%)
     

  • AIM

    754.89
    +1.77 (+0.23%)
     

  • GBP/EUR

    1.1667
    +0.0010 (+0.09%)
     

  • GBP/USD

    1.2516
    +0.0005 (+0.04%)
     

  • Bitcoin GBP

    51,261.19
    +630.61 (+1.25%)
     

  • CMC Crypto 200

    1,388.93
    -7.61 (-0.54%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CRUDE OIL

    84.27
    +0.70 (+0.84%)
     

  • GOLD FUTURES

    2,353.40
    +10.90 (+0.47%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,064.85
    +147.57 (+0.82%)
     

  • CAC 40

    8,051.66
    +35.01 (+0.44%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Fresenius Medical Care confirms 2019 targets

Reuters

(Reuters) - German dialysis specialist Fresenius Medical Care <FMEG.DE> reported on Tuesday a 3% rise in its second-quarter revenue, citing healthy growth in its U.S. dialysis business.

The company confirmed its full-year guidance and still expects sales to rise by 3% to 7%, and adjusted net income change to be in the range of -2% to 2%, after second-quarter revenue came in broadly in line with analysts' expectations in a Refinitiv poll.

(Reporting by Bartosz Dabrowski in Gdynia; Editing by Tomasz Janowski)